Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Risk Pathway Is Involved in Oxytocin Postconditioning in Isolated Rat Heart Publisher Pubmed



Polshekan M1 ; Jamialahmadi K2, 3 ; Khori V4 ; Alizadeh AM5 ; Saeidi M6 ; Ghayourmobarhan M7 ; Jand Y4 ; Ghahremani MH8 ; Yazdani Y9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Department of Modern Science and Technology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  5. 5. Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Stem cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  7. 7. Biochemistry of Nutrition Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Faculty of Modern Science and Technology, Golestan University of Medical Sciences, Gorgan, Iran

Source: Peptides Published:2016


Abstract

The reperfusion injury salvage kinase (RISK) pathway is a fundamental signal transduction cascade in the cardioprotective mechanism of ischemic postconditioning. In the present study, we examined the cardioprotective role of oxytocin as a postconditioning agent via activation of the RISK pathway (PI3K/Akt and ERK1/2). Animals were randomly divided into 6 groups. The hearts were subjected under 30 minutes (min) ischemia and 100 min reperfusion. OT was perfused 15 min at the early phase of reperfusion. RISK pathway inhibitors (Wortmannin; an Akt inhibitor, PD98059; an ERK1/2 inhibitor) and Atosiban (an OT receptor antagonist) were applied either alone 10 min before the onset of the ischemia or in the combination with OT during early reperfusion phase. Myocardial infarct size, hemodynamic factors, ventricular arrhythmia, coronary flow and cardiac biochemical marker were measured at the end of reperfusion. OT postconditioning (OTpost), significantly decreased the infarct size, arrhythmia score, incidence of ventricular fibrillation, Lactate dehydrogenase and it increased coronary flow. The cardioprotective effect of OTpos was abrogated by PI3K/Akt, ERK1/2 inhibitors and Atosiban. Our data have shown that OTpost can activate RISK pathway mostly via the PI3K/Akt and ERK1/2 signaling cascades during the early phase of reperfusion. © 2016 Elsevier Inc.
Other Related Docs